Roivant Sciences Ltd. - 02 Aug 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
10%+ Owner
Signature
/s/ Marianne Romeo Dinsmore, as Authorized Signatory
Issuer symbol
IMVT
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
4
Filing time
02 Aug 2021, 21:46:46 UTC
Next filing
20 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock, $0.0001 par value per share Other +17,021,276 +30% 73,388,664 02 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 2, 2021, Roivant and Immunovant, Inc. ("Immunovant") entered into a Share Purchase Agreement pursuant to which Roivant purchased 17,021,276 shares of Immunovant's common stock for an aggregate purchase price of $200,000,000, in cash, representing a per share price of $11.75.